I just wanted to add one thing. We must remember that the drugs from suppliers in India are generic drugs and these are the drugs we are currently using to treat patients with HIV. For the most part, they are first-line antiretroviral drugs. That is why we now have 5.2 million people undergoing treatment. Most of them are taking the generic drugs from India.
In the last few years up to now, we have noticed an increase in the number of people who have had to change their regimen to follow a second-line antiretroviral treatment. Under Indian legislation, these products have had patent protection since 2005. So it is not possible to get these drugs in generic form because it is not possible to produce a generic version under Indian legislation. So the drug access crisis will become worse in the future since costs will go up, especially when there is no competition on that market.